Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2141741rdf:typepubmed:Citationlld:pubmed
pubmed-article:2141741lifeskim:mentionsumls-concept:C0003062lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C0039011lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C0522536lld:lifeskim
pubmed-article:2141741lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:2141741pubmed:issue6lld:pubmed
pubmed-article:2141741pubmed:dateCreated1990-7-31lld:pubmed
pubmed-article:2141741pubmed:abstractTextPrevious studies utilizing a recombinant MHC haplo-type in our partially inbred miniature swine herd have demonstrated that some recipients matched only for SLA class II show long-term acceptance of renal allografts without exogenous immunosuppression. Such animals have been shown to develop systemic tolerance as evidenced by prolonged rejection times of subsequent donor-specific, but not third-party, skin grafts. In the present studies in vitro cellular responses of long-term tolerant animals and of 7 animals studied sequentially are presented. Long-term tolerant animals demonstrated responses consistent with the absence of the class I reactive helper populations normally present in naive controls. Animals studied sequentially segregated into two groups based on cellular reactivity and survival. All animals showed complete loss of antidonor class I cell-mediated lymphocytolytic (CML) reactivity by postoperative day 10. However, animals surviving less than 20 days maintained CML reactivity to donor class I plus third-party class II in the posttransplant period, while animals surviving greater than 40 days lost such reactivity. Addition of exogenous interleukin 2 could not reverse this loss. These studies suggest that tolerance induction to a renal allograft across a class I only difference involves effects on both helper and killer class I reactive cell populations.lld:pubmed
pubmed-article:2141741pubmed:languageenglld:pubmed
pubmed-article:2141741pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2141741pubmed:citationSubsetIMlld:pubmed
pubmed-article:2141741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2141741pubmed:statusMEDLINElld:pubmed
pubmed-article:2141741pubmed:monthJunlld:pubmed
pubmed-article:2141741pubmed:issn0041-1337lld:pubmed
pubmed-article:2141741pubmed:authorpubmed-author:SuzukiTTlld:pubmed
pubmed-article:2141741pubmed:authorpubmed-author:SakamotoKKlld:pubmed
pubmed-article:2141741pubmed:authorpubmed-author:SachsD HDHlld:pubmed
pubmed-article:2141741pubmed:authorpubmed-author:LunneyJ KJKlld:pubmed
pubmed-article:2141741pubmed:authorpubmed-author:GuzzettaP CPClld:pubmed
pubmed-article:2141741pubmed:authorpubmed-author:ChesterC HCHlld:pubmed
pubmed-article:2141741pubmed:authorpubmed-author:KortzE OEOlld:pubmed
pubmed-article:2141741pubmed:issnTypePrintlld:pubmed
pubmed-article:2141741pubmed:volume49lld:pubmed
pubmed-article:2141741pubmed:ownerNLMlld:pubmed
pubmed-article:2141741pubmed:authorsCompleteYlld:pubmed
pubmed-article:2141741pubmed:pagination1142-9lld:pubmed
pubmed-article:2141741pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:meshHeadingpubmed-meshheading:2141741-...lld:pubmed
pubmed-article:2141741pubmed:year1990lld:pubmed
pubmed-article:2141741pubmed:articleTitleMechanism of tolerance following class I--disparate renal allografts in miniature swine. Cellular responses of tolerant animals.lld:pubmed
pubmed-article:2141741pubmed:affiliationImmunology Branch, National Cancer Institute of Health, Bethesda, Maryland 20892.lld:pubmed
pubmed-article:2141741pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2141741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2141741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2141741lld:pubmed